Usana Health Sciences Inc

Usana Health Sciences Inc

USNA

Get informed when a big investor buys or sells

+ Follow
Market Cap$337.87M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Usana Health Sciences IncUsana Health Sciences Inc37.9-2%0.4-
$45.90

Current Fair Value

153.2% upside

Undervalued by 153.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$337.87 Million
Enterprise Value$189.12 Million
Dividend Yield$- (-)
Earnings per Share$0.58
Beta0.77
Outstanding Shares18,398,000

Return

Return on Equity1.63%ROE
Return on Assets1.20%
Return on Invested Capital8.37%

Valuation & Multiples

P/E Ratio37.94P/E Ratio
PEG-189.06PEG
Price to Sales0.36Price to Sales
Price to Book Ratio0.57Price to Book Ratio
Enterprise Value to Revenue0.2
Enterprise Value to EBIT3.63
Enterprise Value to Net Income21
Total Debt to Enterprise0.07
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 5, 2026
EPS Estimate
$0.44
Average shareholder expectation
Revenue Estimate
$240.99 M
Average shareholder expectation

Next Earnings Call

Expected Date
July 28, 2026
EPS Estimate
$0.43
Average shareholder expectation
Revenue Estimate
$235.00 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts10,100▼ 21.09%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %56.15%▼ 0.29%
Total Invested$179.58M▼ 12.76%
Investors Holding139▲ 19.00%

ESG Score

No data

About Usana Health Sciences Inc

CEO: Kevin Guest